Hims & Hers Health Inc Ordinary Shares - Class A HIMS 深 滬
等待開盤 09-20 09:30:00 美东时间
16.92
+0.610
+3.74%
華盛通- 最 高17.19
- 今 開17.12
- 成交量 679.45万股
- 最 低 16.63
- 昨 收 16.31
- 總市值 36.21亿
- 52周最高 25.74
- 市盈率 靜 --
- 換手率 3.18%
- 52周最低 5.65
- 委 比 60.08%
- 總股本 2.14亿
- 歷史最高 25.74
- 量 比 1.01
- 振 幅 3.43%
- 歷史最低 2.72
- 每 手 1
- 風險率 5.28%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Hims & Hers宣布向美国特定职业人群提供低价的复合版本Wegovy
美国远程医疗服务公司Hims & Hers Health周三宣布推出一项新计划，将以每月99美元的优惠价格向某些职业的患者提供诺和诺德“减肥神药”We...
09-19 10:24
Hims & Hers compounded weight loss med $99/month for military, first responders
U.S. military personnel and veterans, as well as first responders, nurses, and teachers can get a compounded version of the GLP-1 medication semaglutide for as low as $99 a month from Hims & Hers Heal...
09-19 01:40
Paramount Global goes ex dividend Monday
Paramount Global (NASDAQ:PARAA) had declared $0.05/share quarterly dividend, Payable Oct. 1; for shareholders of record Sept. 16; ex-div Sept. 16. See PARAA Dividend Scorecard, Yield Chart, & Dividend...
09-14 02:44
Noom launches cheaper compounded versions of Novo's semaglutide
Noom said that it plans to offer compounded formulations of Novo Nordisk’s (NVO) popular GLP-1 drug semaglutide at discount prices as part of a new weight-loss program called Noom GLP-1 Rx that includ...
09-13 01:57
Each U.S. state has at least 20% of adults living with obesity: CDC
Latest data from the Centers for Disease Control and Prevention (CDC) indicate that obesity prevalence among U.S. adults remains high, with at least one in five adult Americans in each state living wi...
09-13 00:57
Hims & Hers Health files for mixed securities shelf.
Hims & Hers Health (NYSE:HIMS) filed for mixed securities shelf. Filing More on Hims & Hers Health Hims & Hers Health Post Q2 Earnings: Compounded GLP-1 Ploy Faces New Threats (Rating Downgrade) Hims ...
09-10 04:29
快讯 | Hims & Hers Health Inc提交了混合股票上市申请; 规模未披露 - 根据美国证券交易委员会的文件
Hims & Hers Health Inc Files for Mixed Shelf; Size Not Disclosed - SEC Fili...
09-10 04:03
Battle Over Compounded Weight-Loss Medications - Sustainability and Regulation
Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing sustainability challenges.
09-06 00:47
Novo Nordisk warns of continued Ozempic shortage in Q4
Novo Nordisk (NVO) has said in a note published by the European Medicines Agency that the supply shortage of its diabetes drug Ozempic (semaglutide) will continue into the fourth quarter of 2024. The ...
09-03 19:14
礼来“小瓶装”Zepbound问世后，靠着仿制版减肥药大火的Hims & Hers(HIMS.US)股价暴跌
周二，礼来公司宣布将推出其热门减肥药Zepbound 的小瓶廉价版，随后 Hims & Hers Health 股价大跌。
08-28 17:18
